These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16805858)

  • 1. Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes.
    Levy JH
    J Thromb Haemost; 2006 Sep; 4(9):1875-8. PubMed ID: 16805858
    [No Abstract]   [Full Text] [Related]  

  • 2. Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: no.
    Karkouti K; Beattie WS
    J Thromb Haemost; 2006 Sep; 4(9):1879-81. PubMed ID: 16803464
    [No Abstract]   [Full Text] [Related]  

  • 3. Pro: tranexamic acid is better than aprotinin in decreasing bleeding after cardiac surgery.
    Guenther CR
    J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):471-3. PubMed ID: 7524719
    [No Abstract]   [Full Text] [Related]  

  • 4. Con: tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery.
    Murkin JM
    J Cardiothorac Vasc Anesth; 1994 Aug; 8(4):474-6. PubMed ID: 7524720
    [No Abstract]   [Full Text] [Related]  

  • 5. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
    [No Abstract]   [Full Text] [Related]  

  • 6. Suction, salvage, sutures, and potions: blood management post-aprotinin.
    Baker RA
    Semin Cardiothorac Vasc Anesth; 2009 Jun; 13(2):122-6. PubMed ID: 19617252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro: the routine use of aprotinin during pediatric cardiac surgery is a benefit.
    D'Errico CC; Munro HM; Bove EL
    J Cardiothorac Vasc Anesth; 1999 Dec; 13(6):782-4. PubMed ID: 10622665
    [No Abstract]   [Full Text] [Related]  

  • 8. Con: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
    Beattie WS; Karkouti K
    Anesth Analg; 2006 Dec; 103(6):1360-4. PubMed ID: 17122203
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aprotinin reduces homologous blood transfusions when pediatric cardiac surgery must be redone].
    Ohuchi H; Okabe H; Nagata N; Kaneko Y
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):1980-5. PubMed ID: 8958711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of aprotinin in cardiac surgery.
    Levy JH
    Orthopedics; 2004 Jun; 27(6 Suppl):s659-62. PubMed ID: 15239553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprotinin and cardiac surgery.
    DeAnda A
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):492-4. PubMed ID: 18329458
    [No Abstract]   [Full Text] [Related]  

  • 13. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
    Hill SE
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):298-301. PubMed ID: 17418753
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery.
    Landis RC; Asimakopoulos G; Poullis M; Thompson R; Nourshargh S; Haskard DO; Taylor KM
    Heart Surg Forum; 2001; 4 Suppl 1():S35-9. PubMed ID: 11178306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of high-dose aprotinin during nonprimary cardiovascular surgery: case reports and review of the literature.
    Whitten CW; Allison PM; Morse LM; Latson TW
    J Clin Anesth; 1994; 6(6):515-20. PubMed ID: 7533505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Commentary on the article of Dennis T. Mangano: Aprotinin and risks in cardiac surgery].
    Bizouarn P
    Ann Fr Anesth Reanim; 2006 Jul; 25(7):791-5. PubMed ID: 16839738
    [No Abstract]   [Full Text] [Related]  

  • 17. Aprotinin dosing: how much is enough?
    Niimi KS
    J Extra Corpor Technol; 2004 Dec; 36(4):384-90. PubMed ID: 15679284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin and hemostasis monitoring concerns during cardiac surgery.
    Swartz MF; Fink GW; Searles B
    J Extra Corpor Technol; 2004 Dec; 36(4):375-83. PubMed ID: 15679283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin and renal dysfunction: what does history teach us?
    Augoustides JG
    Expert Opin Drug Saf; 2009 Jan; 8(1):5-7. PubMed ID: 19236213
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of aprotinin in Norway.
    Bjella L; Greiff G; Pleym H; Stenseth R; Wahba A
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):261; author reply 261. PubMed ID: 17261150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.